Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe chronic spontaneous urticaria (CSU).
Epistemonikos ID: 6b3f849e9d336c97fbdef31aeaa8504f7692e5c0
First added on: Mar 27, 2025